Iran vs United Kingdom: The number of people with susceptibility test result for rifampicin
Iran
1,828
in 2021
United Kingdom
1,734
in 2021
Iran rank
51st
United Kingdom rank
54th
The number of people with susceptibility test result for rifampicin over time
- Iran
- United Kingdom
How they compare
Iran currently reports 1,828 against 1,734 in United Kingdom, a difference of 94.
That makes Iran's figure about 1.1 times United Kingdom's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Iran ahead.
Iran ranks 51st and United Kingdom ranks 54th of 155 countries.
Across the 2 decades both report, Iran averaged higher in 1 and United Kingdom in 1.
Head to head by decade
| Decade | Iran | United Kingdom | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3,008 | 1,947 | 1,061 | Iran |
| 2020s | 1,608 | 1,640 | 32.5 | United Kingdom |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Iran or United Kingdom?
- Iran, at 1,828 against 1,734 in United Kingdom as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Iran and United Kingdom?
- 94, with Iran ahead.
- How many years of comparable data are there for Iran and United Kingdom?
- 5 years are reported by both, from 2017 to 2021.
- How do Iran and United Kingdom rank globally for the number of people with susceptibility test result for rifampicin?
- Iran ranks 51st and United Kingdom ranks 54th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.